CA3036417A1 - Estimation d'etats physiologiques sur la base de changements dans le cri - Google Patents
Estimation d'etats physiologiques sur la base de changements dans le cri Download PDFInfo
- Publication number
- CA3036417A1 CA3036417A1 CA3036417A CA3036417A CA3036417A1 CA 3036417 A1 CA3036417 A1 CA 3036417A1 CA 3036417 A CA3036417 A CA 3036417A CA 3036417 A CA3036417 A CA 3036417A CA 3036417 A1 CA3036417 A1 CA 3036417A1
- Authority
- CA
- Canada
- Prior art keywords
- patient
- cri
- data
- physiological
- values
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000035790 physiological processes and functions Effects 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 179
- 238000006703 hydration reaction Methods 0.000 claims abstract description 110
- 230000036571 hydration Effects 0.000 claims abstract description 109
- 239000012530 fluid Substances 0.000 claims abstract description 87
- 230000001447 compensatory effect Effects 0.000 claims abstract description 58
- 239000008280 blood Substances 0.000 claims description 68
- 210000004369 blood Anatomy 0.000 claims description 68
- 238000012544 monitoring process Methods 0.000 claims description 47
- 230000018044 dehydration Effects 0.000 claims description 35
- 238000006297 dehydration reaction Methods 0.000 claims description 35
- 230000036772 blood pressure Effects 0.000 claims description 28
- 238000012360 testing method Methods 0.000 claims description 27
- 230000000004 hemodynamic effect Effects 0.000 claims description 25
- 238000004891 communication Methods 0.000 claims description 21
- 206010009192 Circulatory collapse Diseases 0.000 claims description 18
- 238000005259 measurement Methods 0.000 claims description 16
- 210000000707 wrist Anatomy 0.000 claims description 16
- 230000000747 cardiac effect Effects 0.000 claims description 9
- 206010020919 Hypervolaemia Diseases 0.000 claims description 5
- 238000007917 intracranial administration Methods 0.000 claims description 4
- 230000000750 progressive effect Effects 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 2
- 230000002250 progressing effect Effects 0.000 claims description 2
- 238000001802 infusion Methods 0.000 abstract description 3
- 208000032843 Hemorrhage Diseases 0.000 description 25
- 238000004422 calculation algorithm Methods 0.000 description 25
- 230000000740 bleeding effect Effects 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 20
- 238000002637 fluid replacement therapy Methods 0.000 description 18
- 238000010586 diagram Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 238000001631 haemodialysis Methods 0.000 description 12
- 230000000322 hemodialysis Effects 0.000 description 12
- 230000001225 therapeutic effect Effects 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 230000003094 perturbing effect Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 230000003936 working memory Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 239000000446 fuel Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000007792 addition Methods 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000015654 memory Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 208000001953 Hypotension Diseases 0.000 description 3
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000000386 athletic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000010836 blood and blood product Substances 0.000 description 3
- 229940125691 blood product Drugs 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000017488 activation-induced cell death of T cell Effects 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000000205 computational method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000002542 deteriorative effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101100126626 Drosophila melanogaster Itpr gene Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 101000704899 Momordica charantia Ribosome-inactivating protein beta-momorcharin Proteins 0.000 description 1
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002618 extracorporeal membrane oxygenation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 101150059312 lnpkb gene Proteins 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000035761 normovolemia Effects 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4875—Hydration status, fluid retention of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6825—Hand
- A61B5/6826—Finger
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Primary Health Care (AREA)
- Psychiatry (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
L'invention concerne de nouveaux outils et techniques permettant d'évaluer, de prédire et/ou d'estimer un état physiologique d'un patient, sur la base d'une variation de l'indice de réserve compensatoire (CRI) du patient avant, pendant, et/ou après une perturbation physique. Selon certains modes de réalisation, le système peut recevoir un premier ensemble de données physiologiques en provenance d'un ou de plusieurs capteurs à un premier temps en relation avec une perturbation physique du patient, et peut calculer un premier ensemble de valeurs CRI du patient. Le système peut recevoir un second ensemble de données physiologiques à un second temps en relation avec la perturbation physique, calculer un second ensemble de valeurs CRI, analyser les deux ensembles de valeurs CRI par rapport à un modèle préexistant, estimer un état physiologique (par exemple, l'hydratation, etc.) du patient, et afficher l'estimation sur un dispositif d'affichage. Le système peut également commander un dispositif de perfusion afin d'injecter par perfusion des fluides à un patient sur la base de l'état d'hydratation estimé.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562216187P | 2015-09-09 | 2015-09-09 | |
| US62/216,187 | 2015-09-09 | ||
| US201662349516P | 2016-06-13 | 2016-06-13 | |
| US62/349,516 | 2016-06-13 | ||
| PCT/US2016/051130 WO2017044868A1 (fr) | 2015-09-09 | 2016-09-09 | Estimation d'états physiologiques sur la base de changements dans le cri |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3036417A1 true CA3036417A1 (fr) | 2017-03-16 |
Family
ID=58240884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3036417A Abandoned CA3036417A1 (fr) | 2015-09-09 | 2016-09-09 | Estimation d'etats physiologiques sur la base de changements dans le cri |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3346909A4 (fr) |
| CA (1) | CA3036417A1 (fr) |
| WO (1) | WO2017044868A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512260B2 (en) | 2008-10-29 | 2013-08-20 | The Regents Of The University Of Colorado, A Body Corporate | Statistical, noninvasive measurement of intracranial pressure |
| US11382571B2 (en) | 2008-10-29 | 2022-07-12 | Flashback Technologies, Inc. | Noninvasive predictive and/or estimative blood pressure monitoring |
| US11406269B2 (en) | 2008-10-29 | 2022-08-09 | Flashback Technologies, Inc. | Rapid detection of bleeding following injury |
| US11478190B2 (en) | 2008-10-29 | 2022-10-25 | Flashback Technologies, Inc. | Noninvasive hydration monitoring |
| US11395634B2 (en) | 2008-10-29 | 2022-07-26 | Flashback Technologies, Inc. | Estimating physiological states based on changes in CRI |
| US11857293B2 (en) | 2008-10-29 | 2024-01-02 | Flashback Technologies, Inc. | Rapid detection of bleeding before, during, and after fluid resuscitation |
| US11395594B2 (en) | 2008-10-29 | 2022-07-26 | Flashback Technologies, Inc. | Noninvasive monitoring for fluid resuscitation |
| WO2013016212A1 (fr) | 2011-07-22 | 2013-01-31 | Flashback Technologies, Inc. | Moniteur de la réserve hémodynamique et contrôle de l'hémodialyse |
| US11918386B2 (en) | 2018-12-26 | 2024-03-05 | Flashback Technologies, Inc. | Device-based maneuver and activity state-based physiologic status monitoring |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060195041A1 (en) * | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
| US20070021678A1 (en) * | 2005-07-19 | 2007-01-25 | Cardiac Pacemakers, Inc. | Methods and apparatus for monitoring physiological responses to steady state activity |
| US11382571B2 (en) * | 2008-10-29 | 2022-07-12 | Flashback Technologies, Inc. | Noninvasive predictive and/or estimative blood pressure monitoring |
| US11478190B2 (en) * | 2008-10-29 | 2022-10-25 | Flashback Technologies, Inc. | Noninvasive hydration monitoring |
| EP2881034B1 (fr) * | 2009-06-30 | 2020-06-10 | Edwards Lifesciences Corporation | Surveillance et affichage de l'état d'un patient |
| WO2013016212A1 (fr) * | 2011-07-22 | 2013-01-31 | Flashback Technologies, Inc. | Moniteur de la réserve hémodynamique et contrôle de l'hémodialyse |
| US20150088002A1 (en) * | 2013-09-21 | 2015-03-26 | Leo Technologies, Inc. | Hydration monitoring |
| EP3057507A4 (fr) * | 2013-11-14 | 2017-07-12 | Flashback Technologies, Inc. | Surveillance d'hydratation non invasive |
-
2016
- 2016-09-09 WO PCT/US2016/051130 patent/WO2017044868A1/fr active Application Filing
- 2016-09-09 CA CA3036417A patent/CA3036417A1/fr not_active Abandoned
- 2016-09-09 EP EP16845202.7A patent/EP3346909A4/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017044868A1 (fr) | 2017-03-16 |
| EP3346909A1 (fr) | 2018-07-18 |
| EP3346909A4 (fr) | 2019-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11395634B2 (en) | Estimating physiological states based on changes in CRI | |
| US11389069B2 (en) | Hemodynamic reserve monitor and hemodialysis control | |
| US20230404412A1 (en) | Rapid detection of bleeding before, during, and after fluid resuscitation | |
| US11944451B2 (en) | Noninvasive monitoring for fluid resuscitation | |
| US11478190B2 (en) | Noninvasive hydration monitoring | |
| US11382571B2 (en) | Noninvasive predictive and/or estimative blood pressure monitoring | |
| US20160038043A1 (en) | Assessing Effectiveness of CPR | |
| US11918386B2 (en) | Device-based maneuver and activity state-based physiologic status monitoring | |
| US20200205734A1 (en) | Ear-Based Physiological State Monitoring | |
| CA3036417A1 (fr) | Estimation d'etats physiologiques sur la base de changements dans le cri | |
| US11395594B2 (en) | Noninvasive monitoring for fluid resuscitation | |
| WO2016061545A1 (fr) | Évaluation de l'efficacité d'une rcp | |
| EP3468457A1 (fr) | Détection rapide du saignement suite à une lésion | |
| US11406269B2 (en) | Rapid detection of bleeding following injury | |
| CA2929819A1 (fr) | Monitorage de la pression sanguine predictive et/ou estimee non invasif | |
| EP2542148A1 (fr) | Perturbations physiques actives pour améliorer la surveillance médicale intelligente | |
| US20230116132A1 (en) | Hemodynamic Reserve Monitor and Hemodialysis Control | |
| WO2022240812A1 (fr) | Détection et différenciation non invasives de sepsis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20220309 |
|
| FZDE | Discontinued |
Effective date: 20220309 |